Arrivent Biopharma target price cut to $20 from $40
AVBP•Citigroup cut its target price for Arrivent Biopharma to $20 from $40.
Related News
Canadian Pacific Kansas City target price cut to $102 from $109
CP•
BridgeBio Pharma: Barclays cuts target price to $156 from $157
BBIO•
US 30-year bond yield hits fresh 24-year high
TLT•
Musk welcomes German backing for Tesla driver assistance tech as group chases EU approval
TSLA•
eBay recommerce report shows global monthly secondhand buying rises to 47% in 2026 from 35% in 2025
EBAY•